An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study with OpenLabel Extension Evaluating the Efficacy and Safety ofDiacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex